Quantitative and qualitative features of acute phase-adverse events following SARS-CoV-2 vaccination in a large sample of people with multiple sclerosis.

Mult Scler Relat Disord · 2022 · PMC9376979 · PMID 35988330

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

a trend towards significancep = .05actually significant

The logistic regression analysis after at least one dose of vaccine showed a significantly higher probability to develop symptoms in pwMS treated with Teriflunomide (OR = 4.5, 95% CI 1.15–17.68, p = .031) and Natalizumab (OR = 4.3, 95% CI 1.08–17.39, p = .039), and a trend towards significance for Dymethilfumarate (OR = 3.68, 95% CI 0.98-13.87, p = .05).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.